Moreover, second generation antipsychotics (SGAs) have a marked propensity to induce increased levels of blood glucose, glycosylated hemoglobin and insulin, higher IR, alterations of blood lipid profiles, weight gain and sometimes frank diabetes mellitus (T2DM) [7–9]. The gene discussed is INS; the disease is diabetes mellitus.